This post was just published on ZYX Short Change Alert.
Agilent (A) is jumping in the pre-market by about 10% on the news that it will combine its life sciences and diagnostics businesses. This move is way overdone. Consider initiating a 30% tranche, preferably in three 10% tranches in the zone of $54.90 to $56.43. The stock is trading at $55.02 as of this writing in the pre-market.
This is suitable only for those who can stand draw-downs as is common under prevailing market conditions. The plan is to add more if the stock goes higher. Stop zone is $61.56 to $62.43. Target zone is $44 to $45. However, if the stock quickly falls to around $50, we are likely to take profits.
